<DOC>
	<DOCNO>NCT03089749</DOCNO>
	<brief_summary>The aim study quantitate Central Nervous System ( CNS ) autoantibody development human blood use ELISA human brain injury , spinal cord injury , intra-axial brain surgery .</brief_summary>
	<brief_title>Characterization Human Autoantibody Titers After Central Nervous System Insult</brief_title>
	<detailed_description>Study Objectives : We aim : 1 . Quantitate CNS autoantibody development human blood use ELISA human brain injury , spinal cord injury , intra-axial brain surgery . We also aim characterize temporal course response . 2 . Characterize CNS autoantibody level correlate specific injury pattern well radiographic clinical measure injury severity . 3 . Determine intercurrent infection history prior CNS insult affect temporal course magnitude autoantibody production .</detailed_description>
	<mesh_term>Brain Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Autoantibodies</mesh_term>
	<criteria>Have severe traumatic brain injury Have spinal cord injury ASIA grade A , B C Undergoing resection intraaxial brain tumor Participant pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>